This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Beijing Kbd Pharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Guocheng Liu: Innovator in Pharmaceutical Compounds
Introduction
Guocheng Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. His work focuses on innovative solutions for diseases associated with platelet aggregation.
Latest Patents
Guocheng Liu holds a patent for "Ribofuranosyl purine compounds, methods for preparing the same and use thereof." This invention relates to specific compounds and the processes for their preparation. The compounds are utilized in the treatment of diseases linked to platelet aggregation and are integral in the manufacture of medicaments for these conditions. The patent also encompasses pharmaceutical compositions and formulations that include these compounds.
Career Highlights
Liu's career is marked by his dedication to advancing pharmaceutical science. He is associated with Beijing Kbd Pharmaceuticals Co., Ltd., where he continues to innovate and contribute to the development of new medical treatments. His expertise in the field has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Guocheng Liu has worked alongside notable colleagues, including Hongguang Du and Zhongren Ding. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Guocheng Liu's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patent on ribofuranosyl purine compounds highlights the potential for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile